UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  April 29, 2004

 

AEROGEN, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

 

2071 Stierlin Court, Suite 100
Mountain View, CA 94043

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (650) 864-7300

 

 

 

Item 12.   Results of Operations and Financial Condition.

 

On April 29, 2004, Aerogen, Inc. issued a press release announcing its financial results for the three months ended March 31, 2004.  A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.

 

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

2

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

	AEROGEN, INC.
Dated:  May 5, 2004	By:	/s/ Robert S. Breuil
	Name:		Robert S. Breuil
	Title:		Chief Financial Officer and Vice President, Corporate Development

 

3

 

INDEX TO EXHIBITS

 

Exhibit Number		Description
99.1		Press Release, dated as of April 29, 2004, entitled “Aerogen, Inc. Reports First Quarter 2004 Financial Results.”

 

4